News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sihuan Pharma Pays $371 Million to Buy Rival



11/29/2010 11:12:15 AM

November 25, 2010 -- Sihuan Pharma will pay 2.4 billion RMB ($371 million) to acquire Dupromise Holdings, a fellow maker of cardio-cerebral vascular drugs. The price, to be paid in installments, is fixed as 12 times the net income of Dupromise’s 2011 net income, with 2.4 billion RMB set as the maximum. The transaction will give Sihuan, already a major player in its market, even more clout. More details....

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES